Importance of the genotypic testing in people living with HIV in the State of Pará, Brazil
DOI:
https://doi.org/10.33448/rsd-v10i12.20117Keywords:
HIV; Genotypic testing; PVHIV; Mutations.Abstract
The present study aimed the characterization of the clinical-epidemiological profile of people living with HIV(PVHIV) living in the state of Pará. We included all people, independent of age or sex, whose samples was sent to the Central laboratory of Pará (LACEN-PA) during 2013 to 2015 for the genotyping HIV testing. The data were obtained through the collection of information in the results reports stored in LACEN-PA. Information were collected as sex, age, level of education, race, year of diagnosis, raison related to the change in therapeutic regimen and presence of mutations. The male gender was predominant, aged between 40 and 50 years or more, brown and with elementary education. Most were diagnosed with HIV between the years 2000 and 2009, with the majority showing changes in the therapeutic regimen. This fact was largely due to the presence of therapeutic failure and intolerance, thus corroborating the presence of mutations. In this present study, we observed an epidemiological profile of PLHIV consistent with the literature, characterized by the prevalence of the male gender, with the age group between 40 and 50 years or more, mixed race and education at the fundamental level. It was also possible to observe a high rate of changes in therapeutic regimens, of therapeutic failure, in addition to high rates of mutations for the pharmacological classes used in antiretroviral therapy. Thus, demonstrating the importance of genotyping exams not only for choosing the most appropriate therapy but also for adopting strategies that seek to improve PLHIV adherence to treatment with antiretrovirals. Further, new studies contributing to understand and to identificate the changes in therapeutic regimens, as well as their contribution to the appearance of mutations and consequent therapeutic failure, are needed.
References
Abreu, S. R. de, Pereira, B. M., Silva, N. M. da, Moura, L. R. P., Brito, C. M. S. de, & Câmara, J. T. (2016). Estudo epidemiológico de pacientes com infecção pelo virus da imunodeficiencia humana Síndrome da Imunodeficência adquirida (HIVAIDS), CAXIAS-MA. Revista Interdisciplinar, 9(4), 132–141.
Azevedo, L. N., Ximenes, R. A. de A., Monteiro, P., Montarroyos, U. R., & Miranda-Filho, D. de B. (2020). Factors associated to modification of first-line antiretroviral therapy due to adverse events in people living with HIV / AIDS. The Brazilian Journal of Infectious Diseases, 24(1), 65–72.
Bhata, D. N., Aryal, U. R., & Khanal, K. (2013). Education: The key to curb HIV and AIDS epidemic. Kathmandu University Medical Journal, 11(42), 158–161. https://doi.org/10.3126/kumj.v11i2.12493
Brasil. (2018). Manejo da infecção pelo hiv em adultos. In Secretaria de Vigilância em Saúde. Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/Aids e das Hepatites Virais. Protocolo.
Brasil, M. da S. (2008). Manual de adesão ao tratamento para pessoas vivendo com HIV e AIDS. In Secretaria de Vigilância em Saúde. Departamento de Vigilância, Prevenção e Controle das Infecções Sexualmente Transmissíveis, do HIV/Aids e das Hepatites Virais. Protocolo.
BRASIL, M. da S. (2020). Boletim Epidemiológico HIV / Aids | 2020. Secretaria de Vigilância Em Saúde, 1, 68.
Brites, C. (2016). Estratégias de troca ( switch ) na terapia antirretroviral atual. Educaçao Medica Continuada, 2.
CDC. (2020). HIV Surveillance Supplemental Report: Estimated HIV Incidence and Prevalence in the United States, 2014–2018. 25(1), 2010–2015.
Cea-Calvo, L., Marín-Jiménez, I., de Toro, J., Fuster-RuizdeApodaca, M. J., Fernández, G., Sánchez-Vega, N., & Orozco-Beltrán, D. (2020). Association between non-adherence behaviors, patients’ experience with healthcare and beliefs in medications: a survey of patients with different chronic conditions. Current Medical Research and Opinion, 36(2), 293–300.
Clutter, D. S., Jordan, M. R., Bertagnolio, S., & Shafer, R. W. (2016). HIV-1 Drug Resistance and Resistance Testing. Infect Genet Evol, 46(1), 292–307.
Domingues, S., Marcos, A., Gomes, T., Cristina, D., & Iii, D. O. (2016). Representações sociais de homens sobre o ser homem e suas implicações para o HIV / AIDS. 24(6), 1–6.
Dourado, I., Maccarthy, S., Reddy, M., Calazans, G., & Gruskin, S. (2015). Revisitando o uso do preservativo no Brasil. Revista Brasileira de Epidemiologia, 18(1), 63–88.
Fry, P. H., Maio, M. C., Maio, M. C., Bastos, F. I., & Santos, R. V. (2007). AIDS tem cor ou raça ? Interpretação de dados e formulação de políticas de saúde no Brasil Does AIDS have a race or color ? Data interpretation and health policymaking in Brazil. Caderno de Saúde Pública, 23(3), 497–523.
Gomes, R. R. de F. M., Ceccato, M. das G. B., Kerr, L. R. F. S., & Guimarães, M. D. C. (2017). Fatores associados ao baixo conhecimento sobre HIV/AIDS entre homens que fazem sexo com homens no Brasil. Cadernos de Saude Publica, 33(10), 1–15.
Irias, S. D. F., Torres, M. K. S., Avelino, M. E. S., Santos, M. B., Queiroz, M. A. F., Freitas, F. B. MacHado, L. F. A. (2019). HIV-1 Transmitted Drug Resistance Mutations in Recently Diagnosed Antiretroviral-Naive Patients in Belém, Pará, Northern Brazil. AIDS Research and Human Retroviruses, 35(2), 121–122.
Jary, A., Dienta, S., Leducq, V., Le Hingrat, Q., Cisse, M., Diarra, A. B., … Maiga, A. I. (2019). Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali. BMC Infectious Diseases, 19(1), 1–8.
MACÊDO, O., DE SOUSA, R. C., Ferreira, L. M., Vasconcelos, P., & Araújo, J. R. (2011). Genotipagem da resistência genotípica secundária aos antirretrovirais em pacientes com aids nos Estados do Pará e Amazonas , Brasil : 2002 a 2006 *. 55(91), 27–34.
Machado, C. V., Lima, L. D. de, & Baptista, T. W. de F. (2017). Health policies in Brazil in times of contradiction: paths and pitfalls in the construction of a universal system. Cadernos de Saude Publica, 33(2), 144–161.
Mbange, A. E., Kaba, D., Diouara, A. A. M., Diop-Ndiaye, H., Ngom-Ngueye, N. F., Dieng, A., … Kane, C. T. (2018). Surveillance of transmitted HIV-1 antiretroviral drug resistance in the context of decentralized HIV care in Senegal and the Ebola outbreak in Guinea. BMC Research Notes, 11(1), 723.
McCluskey, S. M., Siedner, M. J., & Marconi, V. C. (2019). Management of Virologic Failure and HIV Drug Resistance. Infectious Disease Clinics of North America, 33(3), 707–742.
Moura, Pinto, J., Faria, & Rodrigues, M. (2017). Caracterização E Perfil Epidemiológico Das Pessoas Que Vivem Com Hiv / Aids Characterization and Epidemiological Profile of People Living With Hiv / Aids. Rev Enferm UFPE, 11, 5214–5220.
Qiao, Y. chao, Xu, Y., Jiang, D. xiang, Wang, X., Wang, F., Yang, J., & Wei, Y. sheng. (2019). Epidemiological analyses of regional and age differences of HIV/AIDS prevalence in China, 2004–2016. International Journal of Infectious Diseases, 81, 215–220.
Rodriguez, M. C., Torvisco, M. del M. L.-T., & Aceitero, J.-M. R. (2019). VIGILANCIA UNIFICADA DE LA INFECCIÓN POR VIH Y ENFERMEDAD DE SIDA EN EXTREMADURA EN EL PERÍODO 1980-2018. Rev Espanhola Salud Publica, 93, 1–11.
Rouquayrol, M. Z., & GURGEL, M. Rouquayrol: epidemiologia e saúde. 8. ed. Rio de Janeiro: MedBook, 2018. 719 p.
Sá Bandeira, A. C. P. C., Dias Elias, D. B., Cavalcante, M. G., Lima, D. G. L., & Távora, L. G. F. (2017). Antiretroviral changes during the first year of therapy. Revista Da Associacao Medica Brasileira, 63(7), 606–612.
Seyler Lucie, L. P., & Allard, S. D. (2018). Current challenges in the treatment of HIV. Pol Arch Intern Med, 44(0028-3878 LA-eng PT-Journal Article PT-Review PT-Review, Tutorial RN-0 (Anticonvulsants) SB-AIM SB-IM), S4–S9.
Silveira, E. A., Santos, A. S. e. A. de C., Falco, M. de O., Cardoso, R. de C., & Vitorino, P. V. de O. (2018). Association of physical inactivity with hypertension and low educational level in people living with HIV / AIDS. AIDS Care, 30(8), 1004–1009.
Sisay, M., Edessa, D., Ayele, Y., & Getachew, M. (2019). Pattern of and reasons for antiretroviral therapy regimen change among adult HIV/AIDS patients at regional hospital in Eastern Ethiopia: A 10-year retrospective study. SAGE Open Medicine, 7, 205031211982709.
WHO, W. health organization. (2019). HIV/AIDS. World Health Organization, (September), 78.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Aline Cecy Rocha de Lima ; Alexandre Augusto Bentaberry Rosa; Maria Amelia de Oliveira da Costa; Rubens Einar Corrêa Dantas ; Andréa Nazaré Monteiro Rangel da Silva; Jacqueline Cortinhas Monteiro; Rosimar Neris Martins Feitosa
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
